Drug Profile
PV 903
Alternative Names: PV903Latest Information Update: 03 Apr 2007
Price :
$50
*
At a glance
- Originator OSI Pharmaceuticals; University of Adelaide
- Class
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Spontaneous abortion
Most Recent Events
- 03 Apr 2007 Discontinued - Phase-I for Spontaneous abortion in Australia (Vaginal)
- 02 Dec 2003 PV 903 is available for partnering (http://www.gropep.com.au)
- 02 Dec 2003 Preclinical trials in Spontaneous abortion in Australia (Vaginal)